Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH)
This study is ongoing, but not recruiting participants.
Study NCT01489956   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on December 1, 2011.   Last Updated on December 3, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Autoimmune Disorders
Additional conditions recognized in this trial
Autoimmune Diseases
More general conditions related to this trial
Immune System Diseases
Interventions listed in this trial
Subcutaneous Immucothel
Oral KLH followed by immunization
Additional drug interventions recognized in this trial
Keyhole-limpet hemocyanin
More general drug interventions related to this trial
Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Immune Tolerance Network (ITN)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services